Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
India · Delayed Price · Currency is INR 510.65
+11.15 (2.23%)
Apr 2, 2026, 3:29 PM IST
Amrutanjan Health Care Revenue
Amrutanjan Health Care had revenue of 1.41B INR in the quarter ending December 31, 2025, with 14.90% growth. This brings the company's revenue in the last twelve months to 4.88B, up 10.09% year-over-year. In the fiscal year ending March 31, 2025, Amrutanjan Health Care had annual revenue of 4.52B with 7.26% growth.
Revenue (ttm)
4.88B
Revenue Growth
+10.09%
P/S Ratio
3.01
Revenue / Employee
6.63M
Employees
737
Market Cap
14.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.52B | 305.93M | 7.26% |
| Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
| Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
| Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
| Mar 31, 2021 | 3.33B | 712.64M | 27.23% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 17.60B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 6.74B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Beta Drugs | 3.85B |
Amrutanjan Health Care News
- 5 months ago - Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm in Classic Glass Packaging - Business Upturn